Kalis J K, Freund B J, Joyner M J, Jilka S M, Nittolo J, Wilmore J H
Department of Exercise and Sport Sciences, University of Arizona, Tucson 85721.
J Appl Physiol (1985). 1988 Feb;64(2):753-8. doi: 10.1152/jappl.1988.64.2.753.
The effect of beta-adrenergic blockade on the drift in O2 consumption (VO2 drift) typically observed during prolonged constant-rate exercise was studied in 14 healthy males in moderate heat at 40% of maximal O2 consumption (VO2max). After an initial maximum cycle ergometer test to determine the subjects' control VO2max, subjects were administered each of three medications: placebo, atenolol (100 mg once daily), and propranolol (80 mg twice daily), in a randomized double-blind fashion. Each medication period was 5 days in length and was followed by a 4-day washout period. On the 3rd day of each medication period, subjects performed a maximal cycle ergometer test. On the final day of each medication period, subjects exercised at 40% of their control VO2max for 90 min on a cycle ergometer in a warm (31.7 +/- 0.3 degrees C) moderately humid (44.7 +/- 4.7%) environment. beta-Blockade caused significant (P less than 0.05) reductions in VO2max, maximal minute ventilation (VEmax), maximal heart rate (HRmax), and maximal exercise time. Significantly greater decreases in VO2max, VEmax, and HRmax were associated with the propranolol compared with the atenolol treatment. During the 90-min submaximal rides, beta-blockade significantly reduced heart rate. Substantially lower values for O2 consumption (VO2) and minute ventilation (VE) were observed with propranolol compared with atenolol or placebo. Furthermore, VO2 drift and HR drift were observed under atenolol and placebo conditions but not with propranolol. Respiratory exchange ratio decreased significantly over time during the placebo and atenolol trials but did not change during the propranolol trial.(ABSTRACT TRUNCATED AT 250 WORDS)
在中度高温环境下,以最大耗氧量(VO₂max)的40%对14名健康男性进行长时间恒速运动时,研究了β-肾上腺素能阻滞剂对通常观察到的耗氧量漂移(VO₂漂移)的影响。在进行初始最大运动试验以确定受试者的对照VO₂max后,以随机双盲方式给受试者服用三种药物:安慰剂、阿替洛尔(每日一次,100毫克)和普萘洛尔(每日两次,80毫克)。每个药物治疗期为5天,随后是4天的洗脱期。在每个药物治疗期的第3天,受试者进行最大运动试验。在每个药物治疗期的最后一天,受试者在温暖(31.7±0.3摄氏度)、中度潮湿(44.7±4.7%)的环境中,以其对照VO₂max的40%在功率自行车上运动90分钟。β-阻滞剂使VO₂max、最大分钟通气量(VEmax)、最大心率(HRmax)和最大运动时间显著降低(P<0.05)。与阿替洛尔治疗相比,普萘洛尔使VO₂max、VEmax和HRmax的下降幅度更大。在90分钟的次最大骑行过程中,β-阻滞剂显著降低心率。与阿替洛尔或安慰剂相比,普萘洛尔组的耗氧量(VO₂)和分钟通气量(VE)显著更低。此外,在阿替洛尔和安慰剂条件下观察到VO₂漂移和HR漂移,但普萘洛尔条件下未观察到。在安慰剂和阿替洛尔试验期间,呼吸交换率随时间显著下降,但在普萘洛尔试验期间没有变化。(摘要截断于250字)